The European Commission has granted a conditional marketing authorization for the Nuvaxovid vaccine against COVID-19, developed by Novavax. This is the fifth COVID-19 vaccine approved in the EU.
The authorization follows the positive scientific recommendation based on a thorough evaluation of the safety, efficacy and quality of the vaccine by the European Medicines Agency (EMA) and has been approved by the Member States.
European Commission President Ursula von der Leyen said: “At a time when the Omicron variant is spreading rapidly and we need to intensify vaccination and booster dosing, I am particularly pleased with the current approval of the Novavax vaccine.”
“This is the fifth safe and effective vaccine in our vaccine portfolio, which offers a welcome additional protection to the European citizen against the pandemic. May this authorization offer a strong encouragement to all those who have not yet been vaccinated or given a booster dose. “that now is the time to do it.”
For her part, Commissioner for Health and Food Safety Stella Kyriakidou noted that “this is our first protein-based vaccine, which shows many promising results against COVID-19. Vaccination and boosting doses to increase protection against COVID-19 are now more important than ever if we are to stop the wave of infections and deal with the emergence and spread of new variants. ”
“Today we offer another safe and effective vaccine to our citizens, along with a renewed call for vaccination, vaccination, vaccination!” underlined.
Based on the positive opinion of the EMA, the Commission verified all the evidence supporting the marketing authorization and consulted the Member States before granting it.
Source: AMPE
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
